Variant allele fraction of observed ALK point mutations in this study ranged from 2.7% to 60% of all NB cases, with a subclonal (mutated allele fraction <20%) observed in 6 of 16 ALK-mutated samples. This evidence concerns the gene ALK and neuroblastoma.